Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itacitinib with Gemcitabine and Nab-Paclitaxel in Advanced Solid Tumors
NCT01858883Phase 2Completed
- Sponsor
- Incyte
- Start
- Jun 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of itacitinib in solid tumor, pancreatic cancer (PC), sponsored by Incyte. Started Jun 2013; status: completed.
02
Drugs
itacitinib
03
Conditions
solid tumorpancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01858883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01858883.